Novartis AG
NVS News Today: Stay Updated with the Latest Novartis AG News in Real Time
Find NVS news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.
MOLN.SW down 11.14% pre-market Mar 2026: Molecular Partners CHF3.35 (SIX): view
MOLN.SW stock slides 11.14% pre-market to CHF3.35 on SIX; analyst grade, forecasts and catalyst-driven risks
MMTX.SW +8.98% pre-market on SIX: MindMaze Therapeutics CHF 0.48, catalysts
Pre-market: MMTX.SW stock rises 8.98% to CHF 0.48 on SIX; volume up and Meyka AI forecast and grade included
INA.SW Ina Invest Holding AG (SIX) pre-market 14 Mar 2026: Oversold bounce setup
INA.SW stock pre-market analysis for 14 Mar 2026 with technical bounce setup, Meyka AI forecast and price targets
Market closed: MOLN.SW down 11.14% to CHF 3.35 on SIX: catalyst risk ahead
MOLN.SW stock fell 11.14% to CHF 3.35 on SIX; volume 50,587. Key metrics, Meyka grade and price forecast for investors
CHF120.84 Novartis (NOVN.SW, SIX) pre-market 13 Mar 2026: most-active, outlook
Pre-market update: NOVN.SW stock at CHF120.84 with heavy volume on SIX. Meyka AI grade, forecasts and trade setup included.
PHARM.AS Pharming Group (EURONEXT) Q4 preview 11 Mar 2026: catalysts
PHARM.AS stock Q4 earnings preview 11 Mar 2026 — catalysts, guidance and Meyka AI forecast for Pharming Group
MOLN.SW Molecular Partners AG (SIX) CHF 3.75 pre-earnings 11 Mar 2026: key metrics
MOLN.SW stock trades at CHF 3.75 ahead of 11 Mar 2026 earnings, with forecasts showing a CHF 2.35 yearly target and key risks
NOVN.SW Novartis AG SIX after hours CHF122.00 (-1.02%) 10 Mar 2026: Earnings focus
NOVN.SW stock at CHF122.00 after hours on SIX; quick analysis of valuation, volume and Meyka AI forecast
SMI Index March 10: Oil Spike Cools as Swiss Stocks Trim Losses
SMI Index pares early losses as Brent oil pulls back near $100. Swiss stock market down about 0.7% after brief 3% slide. Luxury and healthcare lag; oil, G7 moves, and Iran tensions steer CH risk.